Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Explore well-known S&P 500 index funds for retirement 2024, focusing on performance, costs, and suitability for your plan.
22,695 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...
Taylor Morrison has named Mike Carlo to lead its Sarasota division, tapping a veteran of more than 25 years in homebu...
ETH activity climbs to record levels in Q1 2026 even as price declines and fees shrink. Analysts call it a classic re...
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...
Meta Platforms and Snap compete for digital ad dollars and user engagement. This guide breaks down their revenue engi...
South Korea's grief-tech niche is moving from curiosity to commerce, with AI-generated memorial videos averaging near...
A new era of obesity and diabetes treatment access could lift Lilly stock. This article breaks down how an oral GLP-1...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Stocks and exchange-traded funds tied to PayPal surged after Reuters reported Stripe and Advent International were we...
A wave of options activity suggests a bearish tilt for Tesla ahead of its Q2 earnings, with net short delta near $550...
Anthropic unveils Claude Code Security, an AI system designed to autonomously probe codebases for vulnerabilities, ra...